NHI-2 is a lactate dehydrogenase A (LDHA) inhibitor with an IC50 value of 14.7 µM, demonstrating high selectivity for LDHA over LDHB, for which the IC50 is 55.8 µM. NHI-2 functions as an efficient anti-glycolytic agent, enhancing apoptosis, inducing cell cycle arrest at the S and G2 phases, and exerting broad-spectrum antiproliferative effects in cancer cells. NHI-2 additionally affects extracellular acidification rates and ATP production and has demonstrated tumor growth suppression in murine B78 melanoma models, highlighting its role in cancer metabolism research.
Molecular Weight:
335.28
Purity:
0.99981
CAS Number:
[1269802-97-2]
Formula:
C17H12F3NO3
Target:
Dehydrogenase|||Apoptosis
T24530
* VAT and and shipping costs not included. Errors and price changes excepted
